CPSC official recall · 21057

GSK Consumer Health Recalls Five Excedrin Brands Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning

召回日期：2020-12-23官方最后发布：2020-12-23适用地区：美国

重要：以下安全事实保留 CPSC 官方英文原文，避免翻译改变含义。请通过右侧官方公告确认行动要求。

危险说明 Hazard

Some of the bottles containing the over-the-counter drug can have a hole in the bottom. If there is a hole, children could access and swallow the contents, posing a risk of poisoning. These products contain the substances aspirin and acetaminophen which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA).

受影响产品

Excedrin Migraine Caplets, Excedrin Migraine Geltabs, Excedrin Extra Strength Caplets, Excedrin PM Headache Caplets, and Excedrin Tension Headache Caplets

Units：About 433,600

官方描述 Description

This recall involves 50, 80, 100, 125, 200, 250 and 300-count bottles of Excedrin Migraine Caplets, Excedrin Migraine Geltabs, Excedrin Extra Strength Caplets, Excedrin PM Headache Caplets, and Excedrin Tension Headache Caplets. The bottles are plastic with a child-resistant closure. For a full list of the recalled products, visit www.excedrin.com/products/discontinued.

事故与伤害 Incidents / Injuries

None reported.

官方补救措施 Remedy

Consumers should immediately store the recalled Excedrin bottles out of sight and reach of children and inspect the bottom of the bottle to determine if there is a hole. If there is a hole in the bottle, contact GSK Consumer Relations for information on how to receive a prepaid shipping label for return to receive a full refund. Bottles without a hole can be retained and used as directed.

Options：Refund

消费者联系信息

GSK Consumer Relations at 800-468-7746 from 8 a.m. to 6 p.m. ET Monday through Friday, or online at www.excedrin.com and click on the “safety issue” banner at the top of the page for more information.